Document is current
Any future updates will be listed below
-
Authors
Lindig, Anja http://orcid.org/0000-0001-8675-496X
Hahlweg, Pola
Christalle, Eva
Giguere, Anik
Härter, Martin
von dem Knesebeck, Olaf
Scholl, Isabelle
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (232160533)
Universitätsklinikum Hamburg-Eppendorf (UKE)
- License Information
-
More Information
Article History
Received: 11 August 2020
Accepted: 23 April 2021
First Online: 2 June 2021
Declarations
:
: The study was approved by the Ethics Committee of the Medical Association Hamburg (Germany, study ID PV5368). The study was carried out in accordance to the latest version of the Helsinki Declaration of the World Medical Association. Principles of good clinical practice were respected. Data protection requirements were met. The psychometric evaluation of the IcanSDM was a secondary analysis of data gathered in the SDM implementation study. No administrative permission was required as all data were collected directly by the study team and no medical records were assessed.
: Not applicable.
: PH gave one scientific presentation on shared decision-making during a lunch symposium in 2018, for which she received compensation and travel compensation from GlaxoSmithKline GmbH. AL, EC, AG, MH, OK and IS declared no competing interests.
